Pharma
Co. Tipperary based Shorla acquires cancer drug Jylamvo
The pharmaceutical business has purchased the drug rights from Therakind
Shorla Oncology, a Tipperary based company, has acquired the oncology and autoimmune drug Jylamvo from Therakind for sale on the US market.
The drug can be used to treat a number of conditions and is designed to avoid the need to split or crush pills.
Susan Conroy, chief executive officer of UK company Therakind, said in a statement: “Therakind is pleased that Jylamvo will now become available to patients in the United States providing a ...